# Longitudinal profiling of antigen receptor gene repertoire dynamics in kidney transplant recipients after multiple SARS-CoV-2 vaccinations

**Authors:** Antonios Mingos, Nikolaos Pechlivanis, Georgios Karakatsoulis, Anastasia Anastasiadou, Glykeria Gkoliou, Nikolaos Vastarouchas, Alexandra Siorenta, Smaragdi Marinaki, Paraskevi Tsoutsoura, Myrto Papamentzelopoulou, Vassiliki Pitiriga, Mina Psichogiou, Angelos Hatzakis, Kostas Stamatopoulos, Elisavet Vlachonikola, Anastasia Chatzidimitriou

PMC · DOI: 10.1093/immhor/vlag004 · 2026-02-20

## TL;DR

Repeated SARS-CoV-2 vaccinations in kidney transplant recipients lead to changes in immune repertoires, suggesting improved immune responses over time.

## Contribution

This study shows that multiple SARS-CoV-2 vaccinations can remodel immune repertoires in kidney transplant recipients.

## Key findings

- TR gene repertoire diversity increased and clonality decreased after booster vaccinations.
- IG gene repertoire diversity increased with elevated somatic hypermutation in SARS-CoV-2-specific clonotypes.
- B cell receptor signaling improved after multiple immunizations, indicating reduced anergy.

## Abstract

Kidney transplant recipients (KTRs) exhibit impaired immune responses to vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, remaining vulnerable to severe coronavirus disease 2019 (COVID-19) even after multiple vaccine doses. We hypothesized that repeated SARS-CoV-2 vaccinations in KTRs might promote remodeling of the adaptive immune repertoire. In order to address this hypothesis and gain insight into adaptive immune dynamics in this population, we employed next-generation sequencing (NGS) to determine longitudinal alterations in immunoglobulin (IG) and T cell receptor (TR) gene repertoires following multiple mRNA vaccinations and functional experiments to assess lymphocyte signaling capacity. TR gene repertoire analysis revealed increased diversity and reduced clonality after booster immunizations, indicative of substantial repertoire renewal. Although the relative frequency of SARS-CoV-2-specific TR clonotypes remained stable over time, significant shifts in TRBV gene usage reflected dynamic reshaping of the TR clonal architecture. Parallel IG gene repertoire profiling demonstrated increased diversity and limited oligoclonal expansions after booster mRNA vaccination. These changes were accompanied by elevated levels of somatic hypermutation in IG clonotypes similar to published SARS-CoV-2-specific clonotypes, suggestive of more efficient humoral responses following repeated antigenic exposure. Phospho-specific flow cytometry analysis revealed initially diminished B cell receptor signaling, which was restored following multiple immunizations, consistent with reversal of B cell anergy status. Altogether, our findings support the notion that repeated SARS-CoV-2 vaccinations drive the remodeling of cellular and humoral immune landscapes in KTRs. These results underscore the importance of tailored vaccination strategies to optimize immune protection in immunocompromised individuals.

## Linked entities

- **Diseases:** coronavirus disease 2019 (MONDO:0100096), SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, ZAP70 (zeta chain of T cell receptor associated protein kinase 70) [NCBI Gene 7535] {aka ADMIO2, IMD48, SRK, STCD, STD, TZK}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, SYK (spleen associated tyrosine kinase) [NCBI Gene 6850] {aka IMD82, p72-Syk}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, TRBV19 (T cell receptor beta variable 19) [NCBI Gene 28568] {aka TCRBV17S1A1T, TCRBV19S1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TRBV12-3 (T cell receptor beta variable 12-3) [NCBI Gene 28577] {aka TCRBV12S3, TCRBV8S1, TRBV123}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, TRBV7-2 (T cell receptor beta variable 7-2) [NCBI Gene 28596] {aka TCRBV6S5A1N1, TCRBV6S5A2, TCRBV7S2, TRBV72}, TRA (T cell receptor alpha locus) [NCBI Gene 6955] {aka IMD7, TCRA, TRA@}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TRB (T cell receptor beta locus) [NCBI Gene 6957] {aka TCRB, TRB@}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, TRBV28 (T cell receptor beta variable 28) [NCBI Gene 28559] {aka TCRBV28S1, TCRBV3S1}, TRBV4-1 (T cell receptor beta variable 4-1) [NCBI Gene 28617] {aka BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3) [NCBI Gene 9451] {aka PEK, PERK, WRS}, PLCG2 (phospholipase C gamma 2) [NCBI Gene 5336] {aka APLAID, FCAS3, PLC-IV, PLC-gamma-2}, IGHV4-34 (immunoglobulin heavy variable 4-34) [NCBI Gene 28395] {aka IGHV434, VH}, IGHD (immunoglobulin heavy constant delta) [NCBI Gene 3495], IGH (immunoglobulin heavy locus) [NCBI Gene 3492] {aka IGD1, IGH.1@, IGH@, IGHD@, IGHDY1, IGHJ}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, IGHV3-23 (immunoglobulin heavy variable 3-23) [NCBI Gene 28442] {aka DP47, IGHV323, V3-23, VH26}
- **Diseases:** viral infections (MESH:D014777), COVID-19 (MESH:D000086382), infection (MESH:D007239), SHM (MESH:D013001)
- **Chemicals:** Cy (MESH:D003545), L-glutamine (MESH:D005973), CO2 (MESH:D002245), Alexa Fluor  647 (MESH:C569686), penicillin (MESH:D010406), KTR (-), Alexa Fluor  488 (MESH:C000711379), gentamicin (MESH:D005839), streptomycin (MESH:D013307)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Mus musculus (house mouse, species) [taxon 10090]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925320/full.md

---
Source: https://tomesphere.com/paper/PMC12925320